Publicações

Tumor Mutation Burden and Circulating Tumor Dna in Combined Ctla-4 and Pd-1 Antibody Therapy in Metastatic Melanoma - Results of a Prospective Biomarker Study

AuthID
P-00Q-V7X

Author(s)

Forschner, A

Battke, F

Hadaschik, D

Schulze, M

Weissgraeber, S

Han, CT

Kopp, M

Frick, M

Klumpp, B

Tietze, N

Amaral, T

Martus, P

Sinnberg, T

Eigentler, T

Kelm, U

Garbe, C

Doecker, D

Biskup, S

Tipo de Documento

Article

Year published

2019

Publicado

in JOURNAL FOR IMMUNOTHERAPY OF CANCER, ISSN: 2051-1426

Volume: 7, Número: 1

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1186/s40425-019-0659-0

Pubmed: 31300034

SCOPUS: 2-s2.0-85068916315

Wos: WOS:000475646900004

Source Identifiers

ISSN: 2051-1426

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Tumor Mutation Burden and Circulating Tumor Dna in Combined Ctla-4 and Pd-1 Antibody Therapy in Metastatic Melanoma - Results of a Prospective Biomarker Study

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Tumor Mutation Burden and Circulating Tumor Dna in Combined Ctla-4 and Pd-1 Antibody Therapy in Metastatic Melanoma - Results of a Prospective Biomarker Study

Links Úteis

Ajuda